Skip to main content
logo
Steminent Biotherapeutics Inc. (TPEX:7729)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
195.50
+19.50 (11.08%)
Oct 16, 2026, 1:59 PM CST

Steminent Biotherapeutics Financials Overview

Millions TWD. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
---0.940.642.12
Revenue Growth
---47.96%-70.01%-95.88%
Gross Profit
-3.45-0.79-6.09-1.04-8.93-1.75
Operating Income
-208.54-173.66-162.3-131.46-98.21-75.6
Net Income
-204.46-174.04-158.75-129.23-85.47-124.2
Earnings Per Share
-3.03-2.95-2.84-2.67-1.92-3.52
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
891.65499.18217451.86153.43230.56
Total Debt
69.6173.3663.7875.3855.1619.17
Net Cash (Debt)
822.03425.81153.23376.4898.27211.39
Net Cash Growth
93.05%177.90%-59.30%283.12%-53.51%-
Net Cash Per Share
12.147.222.747.772.216.00

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-173.71-132.31-139.41-114.81-69.2-55.11
Capital Expenditures
-5.12-7.76-87.15-27.46-2.32-0.6
Free Cash Flow
-178.83-140.07-226.57-142.27-71.52-55.71
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
----110.10%--82.32%
Operating Margin
----13970.14%-15442.14%-3564.12%
Pretax Margin
----13733.16%-13439.31%-5855.78%
Profit Margin
----13733.16%-13439.31%-5855.78%
FCF Margin
----15119.02%-11245.28%-2626.69%

Valuation
Selected indicators aren't available for this stock.